Literature DB >> 33881452

ICOS signaling limits regulatory T cell accumulation and function in visceral adipose tissue.

Kristen L Mittelsteadt1,2, Erika T Hayes1,2, Daniel J Campbell1,2,3.   

Abstract

A unique population of Foxp3+ regulatory T cells (TRs) resides in visceral adipose tissue (VAT) that regulates adipose inflammation and helps preserve insulin sensitivity. Inducible T cell co-stimulator (ICOS) is highly expressed on effector (e)TRs that migrate to nonlymphoid tissues, and contributes to their maintenance and function in models of autoimmunity. In this study, we report an unexpected cell-intrinsic role for ICOS expression and downstream phosphoinositide 3-kinase (PI3K) signaling in limiting the abundance, VAT-associated phenotype, and function of TRs specifically in VAT. Icos-/- mice and mice expressing a knock-in form of ICOS that cannot activate PI3K had increased VAT-TR abundance and elevated expression of canonical VAT-TR markers. Loss of ICOS signaling facilitated enhanced accumulation of TRs to VAT associated with elevated CCR3 expression, and resulted in reduced adipose inflammation and heightened insulin sensitivity in the context of a high-fat diet. Thus, we have uncovered a new and surprising molecular pathway that regulates VAT-TR accumulation and function.
© 2021 Mittelsteadt et al.

Entities:  

Year:  2021        PMID: 33881452     DOI: 10.1084/jem.20201142

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8+ tissue-resident memory T cells.

Authors:  Changwei Peng; Matthew A Huggins; Kelsey M Wanhainen; Todd P Knutson; Hanbin Lu; Hristo Georgiev; Kristen L Mittelsteadt; Nicholas N Jarjour; Haiguang Wang; Kristin A Hogquist; Daniel J Campbell; Henrique Borges da Silva; Stephen C Jameson
Journal:  Immunity       Date:  2021-12-20       Impact factor: 31.745

Review 2.  Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues.

Authors:  Kai Yang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

3.  Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.

Authors:  Cindy Orvain; Anne Cauvet; Alexis Prudent; Christophe Guignabert; Raphaël Thuillet; Mina Ottaviani; Ly Tu; Fanny Duhalde; Carole Nicco; Frédéric Batteux; Jérôme Avouac; NingXin Wang; Michelle A Seaberg; Stacey R Dillon; Yannick Allanore
Journal:  Arthritis Res Ther       Date:  2022-01-05       Impact factor: 5.156

4.  Inducible co-stimulator inhibits lipid phagocytosis of human aortic smooth muscle cells by down-regulating CD36 expression.

Authors:  Meng Liang; Xuemin Guo; Heming Wu; Zhixiong Zhong
Journal:  J Thorac Dis       Date:  2022-01       Impact factor: 2.895

Review 5.  Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiology.

Authors:  Darya Malko; Tarek Elmzzahi; Marc Beyer
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 6.  Boosting regulatory T cell function for the treatment of autoimmune diseases - That's only half the battle!

Authors:  Janine Schlöder; Fatemeh Shahneh; Franz-Joseph Schneider; Björn Wieschendorf
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

7.  PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu.

Authors:  Michael C McGee; Tianyi Zhang; Nicholas Magazine; Rezwanul Islam; Mariano Carossino; Weishan Huang
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.